JP Business

Sanofi sees vaccine trial completed in Q1

French drugmaker Sanofi said it still expected its COVID-19 vaccine to complete phase 3 trials in the first quarter, and reported a rise in fourth-quarter sales and earnings. Francis Maguire reports.